Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial
Phase: PHASE2 | Sponsor: Centre for Addiction and Mental Health | Compound: Psilocybin
- Status
- recruiting
- Institution
- Centre for Addiction and Mental Health
- Start date
- 2025-04-01
- End date
- 2027-12-01
- Registry ID
- NCT06518720
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.